How long does it take to become resistant to Sotorasib?

Exact information on how long it takes for resistance to Sotorasib to develop is unclear, as drug resistance is often a complex and multifactorial process. My answer will focus on common mechanisms of drug resistance and some possible factors in the development of resistance.

1. Drug resistance mechanism:

- Clonal evolution: Tumor cells are very dynamic and they can undergo clonal evolution, producing subclones with different genetic mutations. This means that during treatment, certain subclones may harbor mutations that are insensitive to sotoraxib, leading to resistance.

- Drug metabolism: Some patients may develop a metabolic mechanism for the drug in their body, which reduces the effective concentration of the drug and prevents the drug from achieving a sufficient level of inhibition.

- New inhibitory pathways: Tumor cells may circumvent the effects of sotoraxib by activating other survival pathways or finding new survival strategies, thereby developing drug resistance.

2. Individual differences:

- Genetic polymorphisms: An individual's response to a drug may be affected by genetic polymorphisms, which may render some patients more susceptible to drug resistance.

- Genetic background: A patient's genetic background may affect their sensitivity to drugs, and some patients may be born with greater resistance to drugs.

3. Treatment Plan and Patient Management:

- Dosage and Duration: The dose and duration of a drug may affect how a patient responds to the drug. Incorrect dosing may result in insufficient therapeutic efficacy, thereby increasing the risk of drug resistance.

- Monitoring and adjustment: Regularly monitoring the patient's condition and drug concentration, and adjusting the treatment plan when necessary, is one of the important measures to prevent drug resistance.

4. Clinical research and monitoring:

- Clinical Trials: By participating in clinical trials, patients and doctors can get more information about a drug's effectiveness and resistance. This helps to better understand how the drug performs in actual clinical settings.

- Molecular monitoring: The use of molecular monitoring technology, such as liquid biopsy (liquid biopsy), can detect mutations in circulating tumor DNA and help doctors detect signs of drug resistance earlier.

It is important to emphasize that drug resistance is a complex and multi-layered problem, and each patient may have a different experience. Therefore, when patients are using sotoracib or other targeted therapies, they should closely cooperate with their doctors and conduct regular evaluation and monitoring so that the treatment plan can be adjusted when necessary to delay the occurrence of drug resistance to the greatest extent. At the same time, as scientific research continues to advance, new treatment strategies and drugs may continue to emerge, providing patients with more treatment options.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.